Formula: C19H11F3N2O4S, In chemical reaction engineering, simulations are useful for investigating and optimizing a particular reaction process or system. In a article, 1055361-35-7, molcular formula is C19H11F3N2O4S, introducing its new discovery.
The adenosine receptor subfamily consists of the adenosine A1, A2A, A2B, and A3 receptors, which are localized in a variety of tissues throughout the human body. It is, therefore, a challenge to develop receptor specific ligands with improved tissue selectivity. Allosteric modulators could have these therapeutic advantages over orthosteric ligands. In the present study, a series of 2,4-disubstituted quinolines were synthesized on the basis of the structure of LUF6000 (34). Compound 27 (LUF6096) was able to allosterically enhance agonist binding to a similar extent as 34. In addition, this new compound showed low, if any, orthosteric affinity for any of the adenosine receptors. In a functional assay, compound 27 showed improved activity in comparison to 34, as it increased both the intrinsic efficacy and the potency of the reference agonist Cl-IB-MECA at the human adenosine A 3 receptor.
We very much hope you enjoy reading the articles and that you will join us to present your own research about 1055361-35-7, Formula: C19H11F3N2O4S
Reference：
Quinuclidine – Wikipedia,
Quinuclidine | C7H891N | ChemSpider